Company intelligence / Profile preview
SUNHO BioPharmaceutical
- Ownership
- Private
- Employees
- ~117
- Development stage
- Other
Overview
SunHo has a robust pipeline of nine products, six of which are in clinical stages. Their lead programs target major cancers with novel immunocytokines and ADCC-enhanced mAbs. The company leverages three proprietary technology platforms to develop first-in-class/best-in-class biologics that modulate both innate and adaptive immunity. They have established GMP-compliant manufacturing facilities capable of supporting both clinical trials and commercial production needs. Several assets are advancing through late-stage clinical development for solid tumors, autoimmune diseases, and infectious diseases.
- Therapeutic areas
- Infectious DiseasesImmunologyOncologyOther
- Modalities
- Monoclonal antibodies (mAbs)Bispecific antibodiesAntibody-cytokine fusion proteins (immunocytokines)Fusion proteinsNanobodies
- Industry
- Biotech
Drug pipeline
12 assets11 more assets in the full pipeline.
Beyond the preview
Go deeper on SUNHO BioPharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SUNHO BioPharmaceutical.